Compare AHCO & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AHCO | ATRC |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | N/A | 2005 |
| Metric | AHCO | ATRC |
|---|---|---|
| Price | $10.19 | $41.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $13.60 | ★ $52.00 |
| AVG Volume (30 Days) | ★ 1.0M | 572.3K |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $3,255,213,000.00 | $518,304,999.00 |
| Revenue This Year | $1.07 | $16.90 |
| Revenue Next Year | $6.49 | $12.29 |
| P/E Ratio | $18.99 | ★ N/A |
| Revenue Growth | N/A | ★ 15.80 |
| 52 Week Low | $7.11 | $28.29 |
| 52 Week High | $11.63 | $43.11 |
| Indicator | AHCO | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 61.04 | 65.05 |
| Support Level | $10.13 | $38.92 |
| Resistance Level | $10.56 | $42.42 |
| Average True Range (ATR) | 0.38 | 1.66 |
| MACD | 0.09 | 0.55 |
| Stochastic Oscillator | 71.54 | 82.14 |
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.